Coronary Artery Disease
Conditions
Keywords
Percutaneous coronary intervention, Saphenous vein graft, New generation drug-eluting stent, Bare metal stent
Brief summary
Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare one-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.
Interventions
DEVICEnew-DES
with ot without embolic protection device
DEVICEBMS
with ot without embolic protection device
Sponsors
Wojciech Wojakowski
Medical University of Silesia
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* patients after CABG with significant SVG stenosis referred for PCI
Exclusion criteria
* patients who had both types of stents implanted in the same procedure * patients with the old-DES * patients who had PCI of other vascular territories during the same procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| major adverse cardiac and cerebrovascular event | 1 year |
Secondary
| Measure | Time frame |
|---|---|
| death | 1 year |
| myocardial infarction | 1 year |
| target vessel revascularization | 1 year |
| target lesion revascularization | 1 year |
| stroke | 1 year |
Countries
Poland
Outcome results
None listed